The Medical Device sector (comprising medical device, medical equipment, capital equipment and medical technology companies) showed a healthy up arrow last year, with the Top 50 company revenue totaling $328B, up 10% from $299B in 2015.
The M&A market actively contributed to this, with a total value of over $100B worth of transactions completed and $30B pending. Some notable deals include: Abbott’s purchase of St. Jude Medical for $25B, Canon’s acquisition of Toshiba Medical for $5.9B, Danaher’s Cepheid purchase for 3.9B, Stryker adding Sage and Physio-Control for $2.7B and $1.3B, the Dentsply Sirona merger with The Dental Solutions Company, and Allergan’s bid to acquire Acelity for $2.9B.
Here is a snapshot of the Top 50 ranked by 2016 revenue. We have tracked movement up and down the list with regard to both ranking and revenue changes as compared with 2015. Companies are ranked by their 2016 medical revenue as furnished by their annual reports and publicly available sources, Edgar and Morningstar stock information websites (figures of non- U.S. companies were converted to U.S. dollars from various currencies using end of the year exchange rates for 2016 and 2015). Medical device, equipment, and medical technology revenues were extracted from reports to create an equal playing field. We also revised 2015 earnings to align “apples to apples” revenue reporting with 2016 figures. Companies that had revised 2015 revenues from our last year’s report include: Philips, Boston Scientific, Novartis, Danaher, and Abbott.
Companies are ranked by their 2016 revenue as furnished by their annual reports and publicly available sources such as Edgar and Morningstar stock information websites. Figures of non-U.S. companies were converted to U.S. dollars from various currencies.